Search Results for FTC

Showing 1 – 10

FTC Settles Complaint Over Deceptive Marketing of Unapproved Cancer Products By Michael Mezher - Published 12 January 2018

The US Federal Trade Commission (FTC) on Thursday announced it has reached a settlement with CellMark Biopharma related to the company's claims about marketing efforts to sell two of its unapproved products.

Categories: News, US, FDA, FTC, Advertising and Promotion

Tags: FTC, Federal Trade Commission, CellMark

FTC Seeks Comments on Competition in Prescription Drug Markets By Zachary Brennan - Published 19 October 2017

Ahead of a November workshop in which FDA Commissioner Scott Gottlieb will give a keynote address, the Federal Trade Commission (FTC) is seeking comments on a variety of questions related to competition issues in the US prescription drug market.

Categories: News, US, FTC, Business and Leadership, Crisis management, Distribution, Drugs, Regulatory intelligence, Regulatory strategy

Tags: FTC on drug prices

FTC Sues Drugmakers for Not Marketing Authorized Generics By Zachary Brennan - Published 31 March 2016

The Federal Trade Commission (FTC) for the first time ever filed a complaint in federal district court this week alleging that an agreement not to market an authorized generic – often called a “no-AG commitment” – is a form of reverse payment and violates antitrust laws.

Categories: News, US, FTC, Compliance, Crisis management, Government affairs, Product withdrawl and retirement

Tags: FTC, no-AG commitments, pay-for-delay, generic entry, exclusivity

FTC: Pay-For-Delay Deals Decrease Significantly After Supreme Court Ruling By Zachary Brennan - Published 14 January 2016

The number of pay-for-delay settlements decreased significantly in 2014 after a Supreme Court decision in 2013 found that a branded drug manufacturer’s reverse payment to a generic competitor to settle patent litigation can violate antitrust laws.

Categories: News, US, FTC, Drugs, Ethics, Government affairs, Regulatory strategy

Tags: FTC, pay-for-delay, generic competition

US Government Agencies Crack Down on Dietary Supplement Manufacturers By Zachary Brennan - Published 17 November 2015

In partnership with the Department of Justice, Federal Trade Commission and other agencies, the US Food and Drug Administration (FDA), announced that after a yearlong sweep of dietary supplement makers, the agencies have filed civil injunctions and criminal actions against 117 manufacturers and/or distributors of dietary supplements and tainted products falsely marketed as dietary supplements.

Categories: News, China, US, DOJ, FDA, FTC, Compliance, Distribution, Manufacturing, Nutritional and dietary supplements

Tags: USPlabs, FDA, DOJ, FTC, dietary supplements, nutraceuticals, good manufacturing practices

Clinton Urges FDA, FTC to Take Action Against Drug Price Hikes By Zachary Brennan - Published 19 October 2015

In two letters sent Monday, Democratic presidential hopeful Hillary Clinton called on the US Federal Trade Commission (FTC) and US Food and Drug Administration (FDA) to take action against pharmaceutical companies that inflate drug prices and keep generics off the market.

Categories: News, US, FDA, FTC, Distribution, Drugs, Government affairs, Manufacturing, Regulatory strategy

Tags: FTC, FDA, Ostroff, Hillary Clinton, Daraprim, Turing Pharmaceuticals

FTC Takes Action Against Pharmaceutical 'Product Hopping' By Zachary Brennan - Published 02 October 2015

The Federal Trade Commission (FTC) on Thursday criticized the way brand-name drug manufacturers often tweak products' formulations shortly before a generic's entry to market, thereby delaying competition.

Categories: News, US, FTC, Advertising and Promotion, Generic drugs, Due Diligence, Ethics, Government affairs, Regulatory intelligence, Regulatory strategy

Tags: product hopping, FTC, generic drug competition, Mylan, Warner Chilcott

FTC Asks FDA to Reevaluate Framework for Homeopathic Products By Michael Mezher - Published 24 August 2015

The US Food and Drug Administration (FDA) recently announced it was considering changing the way homeopathic products are regulated and asked for input on whether its current regulatory framework for homeopathic products was sufficient.

Categories: News, US, FDA, FTC, Advertising and Promotion, Over the counter drugs, Labeling

Tags: Federal Trade Commission, FTC, Homeopathy, Homeopathic

Experts to Offer Ad, Promo and Labeling Advice at RAPS Virtual Event By Zachary Brousseau - Published 29 May 2015

As the Internet and social media have become increasingly powerful forces in our everyday lives and important sources of information on personal healthcare decisions, regulators, marketers and healthcare companies all have had to contend with a slew of new challenges. RAPS’ virtual event Advertising, Promotion and Labeling: the US Regulated Environment will bring together experts to offer their advice.

Categories: HTML, Articles, Under RAPS, RAPS Events, US, FDA, FTC, RAPS, Advertising and Promotion, Compliance, Labeling

Tags: advertising, promotion, labeling, social media, social media regulation, FDA, FTC

FDA Cracks Down on Companies Using Search Engine Promotion Tactics By Alexander Gaffney, RAC - Published 25 November 2014

The US Food and Drug Administration (FDA) and Federal Trade Commission (FTC) are cracking down on three alleged marketers of unproven Ebola treatments by using an unusual tactic: Cracking down on their use of search engine marketing tactics.

Categories: News, US, FDA, FTC, Advertising and Promotion, Drugs

Tags: Metadata, Meta Data, Metatags, Meta Tags, FTC, Warning Letter